POTASSIUM CITRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Potassium Citrate, and when can generic versions of Potassium Citrate launch?
Potassium Citrate is a drug marketed by Ut Sw Medctr, Ani Pharms, Ascent Pharms Inc, Bionpharma, Hibrow Hlthcare, Rising, Strides Pharma, Teva Pharms Usa Inc, Torrent, and Zydus Pharms. and is included in ten NDAs.
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Potassium Citrate
A generic version of POTASSIUM CITRATE was approved as potassium citrate by RISING on June 9th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POTASSIUM CITRATE?
- What are the global sales for POTASSIUM CITRATE?
- What is Average Wholesale Price for POTASSIUM CITRATE?
Summary for POTASSIUM CITRATE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 62 |
| Drug Prices: | Drug price information for POTASSIUM CITRATE |
| What excipients (inactive ingredients) are in POTASSIUM CITRATE? | POTASSIUM CITRATE excipients list |
| DailyMed Link: | POTASSIUM CITRATE at DailyMed |
Recent Clinical Trials for POTASSIUM CITRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Utah | Phase 2/Phase 3 |
| Columbia University | Phase 2/Phase 3 |
| University of Pittsburgh Medical Center | Phase 2/Phase 3 |
Pharmacology for POTASSIUM CITRATE
| Drug Class | Anti-coagulant Calculi Dissolution Agent |
| Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
| Physiological Effect | Decreased Coagulation Factor Activity |
Medical Subject Heading (MeSH) Categories for POTASSIUM CITRATE
Anatomical Therapeutic Chemical (ATC) Classes for POTASSIUM CITRATE
US Patents and Regulatory Information for POTASSIUM CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ut Sw Medctr | POTASSIUM CITRATE | potassium citrate | FOR SOLUTION;ORAL | 019647-002 | Oct 13, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms Usa Inc | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 209758-001 | Mar 5, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 203546-001 | Aug 6, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ascent Pharms Inc | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214420-003 | Feb 5, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 212779-002 | Jan 14, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hibrow Hlthcare | POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214426-003 | Feb 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
